Redirecting Immune, Lipid and Metabolic Drivers of Early Cardiovascular Disease: The RESET Cohort Study
National University Hospital, Singapore
3,000 participants
Mar 1, 2024
OBSERVATIONAL
Conditions
Summary
Project RESET is a Singapore National Medical Research Council Large Collaborative Grant funded program that brings together a nationwide community of cardiovascular, metabolic, and digital health researchers, as well as clinicians across primary and tertiary care to study the immune, lipid and metabolic drivers of early cardiovascular disease. RESET incorporates a nested randomised controlled trials (RCT) to test the use of a combined digital wearable and AI-human symbiotic lifestyle intervention to halt or reverse the progression of early disease.
Eligibility
Inclusion Criteria2
- -70 years old
- ASCVD (atherosclerotic cardiovascular disease) score of 5% and higher
Exclusion Criteria4
- Previous major cardiovascular disease (myocardial infarction, heart failure, ischemic stroke)
- Limited life expectancy
- Other ongoing unstable medical conditions
- Pregnant women
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Digital wearable and AI-human symbiotic lifestyle intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06211868